Diagnos Laboratorium Utama Tbk. vs LCK Global Kedaton Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while LCK Global Kedaton Tbk. trades at Rp107 (market cap 106B, 23.76M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.9× LCK Global Kedaton Tbk.'s market cap, and LCK Global Kedaton Tbk. is more actively traded (23.76M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | LCKM | |
|---|---|---|
Market Cap | 310.75B | 106B |
Volume | 963.6K | 23.76M |
Lot | 9.64K | 237.58K |
Turnover | 217.67M | 2.57B |
Average Price | 225.89 | 108.06 |
Value | 217.67M | 2.57B |
Indicative Equilibrium Price | 226 | 107 |
Indicative Equilibrium Volume | 1K | 1.28K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT LCK Global Kedaton (the "Company") was established on July 31, 2013 based on Deed of Establishment no. 44 made before Notary Sahat Simanungkalit, SH, M.Kn
Read more on LCKM →